Ivonescimab in the Treatment of Multiple Advanced Tumors

Clinical trial NCT06683846 · RECRUITING

Trial details

NCT number: NCT06683846
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pheochromocytoma/Paraganglioma Rhabdomyosarcoma Paget Disease, Extramammary Renal Angiomyolipoma Perivascular Epithelioid Cell Tumor, Malignant Sarcoma Urachal Cancer Neuroendocrine Cancer Basal Cell Carcinomas Sarcomatoid Carcinoma Penile Cancer Adrenal Cortical Cancer

Start date: 2024-11-20
Primary completion: 2027-11-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.